课题基金 / 基金详情

Benzo[a] pyrene Mutagenic Mechanisms

Benzo[a] pyrene Mutagenic Mechanisms
苯并[a]芘诱变机制
批准号:
6524709
负责人:
EDWARD L LOECHLER
金额:
$36.68万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-06-30 至 2005-08-31

项目摘要

项目成果

EDWARD L LOECHLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant): Benzo[a]pyrene is a potent mutagen/carcinogen found ubiquitously in the environment. It is metabolically activated inside cells to its (+)-anti-7,8-diol-9,10-epoxide giving adducts principally at N2-Gua ([+ta]-B[a]P-N2-dG). Applicant showed that (+)-anti-B[a]PDE induces base substitution, frameshifts, insertions and deletions (studied in E. coli). The question he is addressing is: how does (+)-anti-B[a]PDE induce such a diverse array of mutations? His working hypothesis is that adduct mutational complexity is due to adduct conformational complexity and that the major adduct ([+ta]-B[a]P-N2-Gua) is able to induce the majority of these mutations. Furthermore, adduct conformation may be controlled by various factors, notably, DNA sequence context. We have generated additional data to support his working hypothesis, and have found that [+ta]-B[a]P-N2-dG principally follows the G->T mutational pathway in 5'-TGC sequences (>95 percent), but principally the G->A mutational pathway in a 5'-AGA ( about95 percent) and a 5'-CGY ( about80 percent) sequence context. A correlation between his mutagenesis findings and molecular modeling studies (funded separately) suggested a conformational hypothesis for the induction of G->T vs. G->A mutation. Preliminary findings suggest that this hypothesis is probably not correct. He believes that more data are needed on the effect of DNA sequence context on [+ta]-B[a]P-N2-dG mutagenesis before another hypothesis can be proposed. In addition, he believes that one must understand what polymerase is involved in mutagenic bypass. To this end, three specific aims are proposed. (1) The mutagenic patterns for [+ta]-B[a]P-N2-dG in a 5'-TGT vs. a 5'-UGT context and a 5'-m5CGT- vs. a 5'-CGT context will be compared to evaluate the role of a methyl group on the base to the 5'-side of the adduct to influence the pattern of mutagenesis. This aim relates to a hypothesis for why G->T mutations are high in 5'-TG sequences. (2) [+ta]-B[a]P-N2-dG will be studied in all combinations of sequence contexts 5'-XGY from which sequence context rules for mutagenesis will emerge. These rules (in combination with structural/conformational studies) will be used to generate new ideas for how adduct conformations might induce (e.g.) G->T vs. G->A mutations. The vector in this study will permit the applicant to do studies in both E. coli and human cells in culture. (3) Investigate what E. coli DNA polymerase(s) (notably, DNA polymerases II, IV, V, or UVM) is (are) responsible for G->T vs. G->A mutations for [+ta]-B[a]P-N2-dG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Conference:Mutagenesis and Carcinogenesis
  • 批准号:
    6479700
  • 项目类别:
  • 资助金额:
    $1.1万
  • 财政年份:
    2002
  • 负责人:
    EDWARD L LOECHLER
  • 依托单位:
MUTAGENIC PATHWAYS INVOLVING 5-METHYLCYTOSINE
INTERSTRAND CROSSLINKS--REPLICATION, REPAIR, MUTATIONS
  • 批准号:
    2093199
  • 项目类别:
  • 资助金额:
    $14.09万
  • 财政年份:
    1993
  • 负责人:
    EDWARD L LOECHLER
  • 依托单位:
INTERSTRAND CROSSLINKS--REPLICATION, REPAIR, MUTATIONS
  • 批准号:
    3193201
  • 项目类别:
  • 资助金额:
    $13.53万
  • 财政年份:
    1993
  • 负责人:
    EDWARD L LOECHLER
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: